Adeia Enters into Long-Term IP License Agreement with Astound Broadband
30 avr. 2024 08h30 HE
|
Adeia Inc.
SAN JOSE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the company whose patented innovations shape the way the world explores and experiences entertainment, has entered...
Horizon Group Inspires Creativity Through Partnerships with Top Brands
15 avr. 2024 09h00 HE
|
Horizon Group USA
WARREN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Horizon Group USA, a leading global provider of innovative activity products, continues to keep creativity fun and accessible for families by...
BeatStars Launches New Service to Help Creators Negotiate With Labels and Get Paid Faster
27 mars 2024 15h52 HE
|
BeatStars Inc.
The end-to-end service will provide creators with access to data-driven expert recommendations for licensing, protecting, and getting paid for their IP.
Cingulate to Attend DCAT Week 2024 in New York City
06 mars 2024 06h45 HE
|
Cingulate Inc.
KANSAS CITY, Kan., March 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Global Mofy Metaverse Wins Major New Customer Order
04 mars 2024 09h00 HE
|
Global Mofy Metaverse Limited
Global Mofy Metaverse (Nasdaq: GMM) Wins Major New Customer Order; AI Revolution Driving Accelerated Demand Growth for High-Quality Digital Assets
RegEd Launches Producer Management and Licensing Automation Technology Bundle for Midsized Insurers and Distributors
15 févr. 2024 12h30 HE
|
RegEd
Raleigh, NC, Feb. 15, 2024 (GLOBE NEWSWIRE) -- RegEd, the leading provider of producer management solutions for the insurance and financial services industry, has announced the launch of a...
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
14 févr. 2024 03h00 HE
|
Numab Therapeutics AG
NM49 is a multi-specific antibody identified through Numab’s proprietary discovery and engineering technology platform designed to activate tumor associated macrophage phagocytosis Numab to receive...
VitalHub Announces First Canadian Licensing Agreement of the Award-Winning Intouch with Health Queue Management & Patient Journey Optimization Platform with Newfoundland & Labrador Health Services
12 févr. 2024 07h30 HE
|
VitalHub Corp.
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX:VHI) (OTCQX:VHIBF) is pleased to announce the first Canadian customer for the Intouch with Health Queue...
CryoMass Announces Non-Dilutive Financing Agreement
29 janv. 2024 07h10 HE
|
Cryomass Technologies
CryoMass Announces Non-Dilutive Financing Agreement
Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations
25 janv. 2024 16h05 HE
|
Travere Therapeutics, Inc.
Travere Therapeutics has entered into an exclusive licensing agreement with Renalys Pharma to bring sparsentan to patients in Japan.